In Figure 9E, CDKN2A, CDK4, and CDK6 expression levels were compared across different patient groups, including patients with cirrhosis, HCV-related HCC, non-HCV-related HCC, and parental tissue. Here, CDKN2A is linked to hepatocellular carcinoma.